Market Cap | 113.70B | P/E | 30.30 | EPS this Y | -1.70% | Ern Qtrly Grth | 8.20% |
Income | 4.2B | Forward P/E | 15.68 | EPS next Y | 4.80% | 50D Avg Chg | -1.00% |
Sales | 32.32B | PEG | 4.45 | EPS past 5Y | 3.21% | 200D Avg Chg | 2.00% |
Dividend | 3.00% | Price/Book | 2.21 | EPS next 5Y | 3.48% | 52W High Chg | -11.00% |
Recommedations | 2.50 | Quick Ratio | 1.46 | Shares Outstanding | 1.33B | 52W Low Chg | 13.00% |
Insider Own | 0.11% | ROA | 4.23% | Shares Float | 1.33B | Beta | 0.78 |
Inst Own | 85.25% | ROE | 8.17% | Shares Shorted/Prior | 12.43M/8.45M | Price | 85.46 |
Gross Margin | 65.72% | Profit Margin | 13.00% | Avg. Volume | 5,171,690 | Target Price | 94.00 |
Oper. Margin | 19.17% | Earnings Date | May 23 | Volume | 5,408,180 | Change | -2.53% |
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
RBC Capital | Sector Perform | Feb 21, 24 |
Oppenheimer | Perform | Feb 21, 24 |
Mizuho | Buy | Feb 21, 24 |
Truist Securities | Hold | Feb 21, 24 |
RBC Capital | Sector Perform | Jan 12, 24 |
Truist Securities | Hold | Dec 22, 23 |
RBC Capital | Sector Perform | Nov 22, 23 |
Morgan Stanley | Overweight | Nov 22, 23 |
RBC Capital | Sector Perform | Aug 23, 23 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Wall Brett A. | EVP & Pres Neuroscie.. EVP & Pres Neuroscience | Dec 19 | Sell | 82.17 | 4,997 | 410,603 | 28,910 | 12/20/23 |
Smith Gregory L | EVP Global Ops & Sup.. EVP Global Ops & Supply Chain | Aug 23 | Sell | 83.84 | 10,000 | 838,400 | 46,723 | 08/25/23 |
Wall Brett A. | EVP & Pres Neuroscie.. EVP & Pres Neuroscience | Aug 14 | Sell | 83.38 | 1,000 | 83,380 | 33,573 | 08/16/23 |
Marinaro Michael | EVP & President, Sur.. EVP & President, Surgical OU | Aug 03 | Sell | 84.11 | 1,352 | 113,717 | 28,930 | 08/07/23 |
Salmon Sean | EVP & President Card.. EVP & President Cardiovascular | Dec 13 | Option | 55.32 | 16,631 | 920,027 | 52,719 | 12/16/22 |
Salmon Sean | EVP & President Card.. EVP & President Cardiovascular | Dec 13 | Sell | 80.5 | 16,631 | 1,338,796 | 36,088 | 12/16/22 |
TEN HOEDT ROB | EVP and Pres. Global.. EVP and Pres. Global Regions | Oct 14 | Option | 41.6 | 2,404 | 100,006 | 45,887 | 10/17/22 |
TEN HOEDT ROB | EVP and Pres. Global.. EVP and Pres. Global Regions | Oct 14 | Sell | 81.54 | 2,404 | 196,022 | 43,483 | 10/17/22 |
PARKHILL KAREN L | EVP & Chief Financia.. EVP & Chief Financial Officer | Mar 18 | Sell | 110.00 | 682 | 75,020 | 34,946 | 03/21/22 |
Surface Carol A | SVP, Chief HR Office.. SVP, Chief HR Officer | Mar 11 | Sell | 105.30 | 6,000 | 631,800 | 28,502 | 03/14/22 |
Salmon Sean | EVP & Pres Diabetes/.. EVP & Pres Diabetes/Cardiovasc | Aug 26 | Option | 38.61 | 28,419 | 1,097,258 | 40,619 | 08/26/21 |
Salmon Sean | EVP & Pres Diabetes/.. EVP & Pres Diabetes/Cardiovasc | Aug 26 | Sell | 134.09 | 28,419 | 3,810,704 | 33,329 | 08/26/21 |
Martha Geoffrey | CEO CEO | Aug 26 | Sell | 132.67 | 11,581 | 1,536,451 | 95,836 | 08/26/21 |
Martha Geoffrey | CEO CEO | Aug 26 | Option | 59.04 | 11,581 | 683,742 | 105,936 | 08/26/21 |
Wall Brett A. | EVP & Pres Neuroscie.. EVP & Pres Neuroscience | Jun 22 | Option | 74.84 | 1,168 | 87,413 | 22,655 | 06/22/21 |
Wall Brett A. | EVP & Pres Neuroscie.. EVP & Pres Neuroscience | Jun 22 | Sell | 123.5 | 115 | 14,202 | 21,602 | 06/22/21 |
Liddicoat John R | EVP & President of A.. EVP & President of Americas | Jun 01 | Option | 83.03 | 34,656 | 2,877,488 | 77,207 | 06/01/21 |
WHITE ROBERT JOHN | EVP & Pres. Medical.. EVP & Pres. Medical Surgical | Dec 21 | Sell | 115.46 | 10,930 | 1,261,978 | 44,922 | 12/21/20 |
Lerman Bradley E | SVP General Counsel.. SVP General Counsel & Corp Sec | Nov 10 | Option | 62.76 | 20,715 | 1,300,073 | 74,863 | 11/10/20 |
Lerman Bradley E | SVP General Counsel.. SVP General Counsel & Corp Sec | Nov 10 | Sell | 113.13 | 20,715 | 2,343,488 | 54,148 | 11/10/20 |
ISHRAK OMAR | Executive Chairman Executive Chairman | Oct 14 | Sell | 108.4 | 763 | 82,709 | 561,032 | 10/14/20 |
Lerman Bradley E | SVP General Counsel.. SVP General Counsel & Corp Sec | Oct 09 | Option | 62.76 | 20,714 | 1,300,011 | 55,122 | 10/09/20 |
Lerman Bradley E | SVP General Counsel.. SVP General Counsel & Corp Sec | Oct 09 | Sell | 110 | 20,714 | 2,278,540 | 54,325 | 10/09/20 |